Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/24156 
Erscheinungsjahr: 
2005
Schriftenreihe/Nr.: 
ZEW Discussion Papers No. 05-60
Verlag: 
Zentrum für Europäische Wirtschaftsforschung (ZEW), Mannheim
Zusammenfassung: 
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make different efforts to overcome shortcomings and recent gaps. Public funding schemes have been implemented to establish a flourish biotech industry in Germany. We assume that R&D policy was driven blind by the idea to catch up with world?s biotech leaders and analyse if Germany?s R&D policy lost its origins. We do examine, if Germany sacrifice economic funding principles, in particular not discriminating different kinds of ?risk? in the field of biotechnology. The study combines survey data of German biotech companies and public R&D funding data on the firm level. The results shed light on the factors which determine public R&D funding and firm?s probability of being funded.
Schlagwörter: 
Biotechnology
Public Policy
Innovation
Subsidies
JEL: 
C21
L21
H32
M13
L65
O38
Dokumentart: 
Working Paper

Datei(en):
Datei
Größe
186.5 kB





Publikationen in EconStor sind urheberrechtlich geschützt.